Publikationen von 0000-0002-4238-9486
(ORCID: 0000-0002-4238-9486)

Franklin, Cindy , Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Garzarolli, Marlene, Weichenthal, Michael , Pfoehler, Claudia, Herbst, Rudolf , Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa , Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne und Ugurel, Selma (2022) Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 10 (6), e004509. Volltext nicht vorhanden.

Mohr, Peter, Scherrer, Emilie, Assaf, Chalid, Bender, Marc , Berking, Carola, Chandwani, Sheenu, Eigentler, Thomas , Grimmelmann, Imke, Gutzmer, Ralf , Haferkamp, Sebastian, Hassel, Jessica , Hauschild, Axel , Herbst, Rudolf , Jiang, Ruixuan , Kähler, Katharina, Krepler, Clemens, Kreuter, Alexander , Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund , Pföhler, Claudia, Rudolph, Anja, Schadendorf, Dirk, Schiavone, Maximo, Schley, Gaston, Terheyden, Patrick, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weishaupt, Carsten , Welzel, Julia und Weichenthal, Michael (2022) Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7), S. 1804. Volltext nicht vorhanden.